SIGNATUREFD, LLC - SEATTLE GENETICS INC ownership

SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 490 filers reported holding SEATTLE GENETICS INC in Q2 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of SEATTLE GENETICS INC
ValueSharesWeighting
Q3 2020$50,000
+72.4%
253
+48.8%
0.00%
+50.0%
Q2 2020$29,000
+141.7%
170
+70.0%
0.00%
+100.0%
Q1 2020$12,000
+140.0%
100
+112.8%
0.00%
Q4 2019$5,000
+400.0%
47
+147.4%
0.00%
Q4 2015$1,000
-66.7%
19
-71.6%
0.00%
-100.0%
Q3 2015$3,000
+200.0%
67
+252.6%
0.00%
Q2 2015$1,000190.00%
Other shareholders
SEATTLE GENETICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 50,060,240$5,775,950,00035.57%
Lagoda Investment Management, L.P. 72,969$8,419,0009.97%
Avidity Partners Management LP 580,000$66,920,0009.25%
Arabesque Asset Management Ltd 14,807$1,708,0003.53%
Boxer Capital, LLC 400,000$46,152,0003.15%
Woodline Partners LP 364,333$42,037,0003.00%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 56,900$6,557,0002.99%
SECTORAL ASSET MANAGEMENT INC 107,000$12,346,0002.37%
Capital International, Inc./CA/ 1,197,659$138,186,0002.33%
Bain Capital Public Equity Management II, LLC 169,641$19,573,0002.29%
View complete list of SEATTLE GENETICS INC shareholders